Trading Summary - Week November 4-8. Despite the CEO

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
189
Trading Summary - Week November 4-8.

Despite the CEO putting out another good update this week, the group of 4 scammers on iHub continued their manipulation efforts with the usual combination of walked down asks, paint downs into the bid - for between 1 and 5000 shares - and nonsense posting both about the history and future prospects for the stock. One of them - "Bionic Man" - has even tried sending abusive PMs to me [now blocked] demonstrating that he clearly doesn't recognize how the OTC markets works, who the significant traders in it are, or even how to trade properly.

Currently the iHub scammers are mostly being allowed to speak to themselves on that non-influential forum - but with the occasional post being put up by credible traders to debunk their nonsense. Whilst they have succeeded in painting the stock down - they have not - and will not - succeed in duping any of the significant top trader holders to sell and they have been prevented from picking up any significant amount on the bid in the .2300 > .3000 range.

Overall, a further 18,025 shares were bought this week - slightly more than the 16,751 shares that were bought last week - all in the "as near to .4000 as makes no difference" range.

$EVSV remains the #3 Pick on the Watch List for profit earning potential in 2019 / 2020 - out-trumped only by and $VYST - which will offer $500K > $1M+ profits if the NASDAQ requirement price is met [trading discipline and patience required] and $TMPS which is expected to receive another DoD contract as part of a Multiple Award Contract opportunity being offered for early-2020.

As previously stated, the top traders in $EVSV are not going to waste our time playing in among the manipulation action apart from taking out asks when it suits us and maintaining a basher / flipper reload denial bid.

This will remain the main board for analysis of trading action.

As usual, the TA updated the share structure in a timely manner as at November 1, 2019 - showing no change from the previous update.

I will be updating the DD / Rolling Brief over the weekend - plus keeping an eye out for any updates from WI and FL on hemp or new partnerships.

Items below the line unchanged from previous report and still valid [important points emphasized in bold]:

The 2018 Annual, 2019 Q1 and 2019 Q2 Reports were all filed on time with improved financials.

Don't expect any significant amount to be offered under $1.0000 as it is not unreasonable to expect to see $1 to $2 at some point in 2019 / 2020 based on the thin share structure, the majority of shares being in the hands of savvy traders, and multiple catalysts ahead.

There is still very little in asks under $1.000 and $EVSV should be extremely thin well into the $1 > $2 range based on who had what where prior to the r/s.

There are now 129 x social media alerters / analysts that have $EVSV on their radar now for continued upward movement.

Ahead expect:

- Continued manual and further automatic outbidding.

- Closing of the spread and / or hitting the ask across a wide spread when an artificially low fake ask is seen.

- More hits on the ask.

- Further updates on the progress of entry into the hemp sector - particularly in the other 6 states being considered - as one of the company's diversification efforts.

- Further updates on the pest control business.

- Further updates on a share buyback by the company.

- Further updates on new partnerships.

- Update to the share structure by or soon after November 30, 2019.

- Further updates to the Hemp Division website.

- Confirmation that the first hemp crop harvest has been completed.

Warning ! Anyone I suspect of painting $EVSV down can expect to have their iHub ID sent to the SEC for investigation - particularly when they also make remarks about the stock "going down".

The SEC is starting to take action against those who use the specific modus operandi I have seen being used on $EVSV - contemporaneous records have been kept .

https://www.sec.gov/news/press-release/2019-216

I have noted that the iHub scammer / manipulator nonsense posters in line to be reported to the SEC that have now admitted to having bought shares - which will count against them when their sell orders are checked in any investigation.



Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytokinetics Faces Class Action: What You Need to Know

Updated Category News Views 175

Understanding the Class Action Lawsuit Against Cytokinetics Cytokinetics, Incorporated is currently facing a significant class action lawsuit initiated by shareholders. This legal challenge brings to light serious allegations against the Company regarding their disclosures and expectations for FDA approval of a key drug. Details of the Allegations The lawsuit asserts that...

Continue Reading
Discover the Embodied Luxury of the Champagne Specialist Course

Updated Category News Views 207

Verona Hosts the Esteemed Champagne Specialist Course The Italian Wine Academy is excited to announce a remarkable opportunity for wine enthusiasts and professionals. In Verona, for the very first time, the Academy will conduct the prestigious Comité Champagne 'Champagne Specialist' course. This unique program will be available in both English and Italian, providing an...

Continue Reading
MiniLuxe Achieves Strong Q1 2025 Growth with Strategic Focus

Updated Category News Views 378

MiniLuxe Reports Strong Financial Performance for Q1 2025 Reported figures all in U.S. Dollars MiniLuxe Holding Corp. (TSXV: MNLX) has announced exciting financial results for its first quarter of the year. This period showcased a significant 9% growth in revenue, reaching an impressive $6.1 million. Coupled with a gross profit of $2.5 million, reflective of a 12%...

Continue Reading
Transforming Shopify: AI Product Discovery for Enterprises

Updated Category News Views 141

Fredhopper's New App for Shopify Fredhopper Introduces Cutting-Edge Product Discovery Solutions The ecommerce landscape is evolving rapidly, and innovation is at the forefront. Fredhopper has launched its Product Discovery App for Shopify, bringing advanced AI-powered product search and personalized recommendations directly into the hands of enterprise merchants. This...

Continue Reading
Quantum Computing Inc. Faces Class Action Lawsuit for Shareholders

Updated Category News Views 162

Understanding the Recent Class Action Against Quantum Computing Inc. In a significant turn of events, Quantum Computing Inc. has come under legal pressure as a class action lawsuit has been filed on behalf of its shareholders. The lawsuit comes in response to allegations of misleading information that may have adversely affected investors' financial interests. Class...

Continue Reading